Emetine suppresses SARS-CoV-2 replication by inhibiting interaction of viral mRNA with eIF4E

Emetine is a FDA-approved drug for the treatment of amebiasis. Previously we demonstrated the antiviral efficacy of emetine against some RNA and DNA viruses. In this study, we evaluated the in vitro antiviral efficacy of emetine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) an...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Antiviral Res
Autors principals: Kumar, Ram, Afsar, Mohammad, Khandelwal, Nitin, Chander, Yogesh, Riyesh, Thachamvally, Dedar, Ramesh Kumar, Gulati, Baldev R., Pal, Yash, Barua, Sanjay, Tripathi, Bhupendra N., Hussain, Tanweer, Kumar, Naveen
Format: Artigo
Idioma:Inglês
Publicat: Elsevier B.V. 2021
Matèries:
Short Communication
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7943376/
https://ncbi.nlm.nih.gov/pubmed/33711336
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2021.105056
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars